Short- and mid-term outcomes of Q-wave acute myocardial infarction in elderly women. Are they receiving appropriate treatment?;Evolución a corto y medio plazo del infarto agudo de miocardio transmural en mujeres ancianas. ¿Son tratadas correctamente?

Revista Espanola de Geriatria y Gerontologia

Volumn 42, Issue 3, 2007, Pages 142-148

  Galache Osuna, José G ^a   Ambroj, Cristina Moreno ^a   Lezcano, Juan Sánchez Rubio ^a   Cebollero, Isabel Calvo ^a   Ocampo, Ana Portolés ^a   Guallar, Carmen Aured ^a   Diarte De Miguel, Jose A ^a   Placer Peralta, Luis J ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Acute myocardial infarction; Elderly women; Primary angioplasty; Thrombolysis

Indexed keywords

ACUTE HEART INFARCTION; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; Q WAVE; REPERFUSION; REVASCULARIZATION; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 34547798072     PISSN: 0211139X     EISSN: 15781747     Source Type: Journal    
DOI: 10.1016/S0211-139X(07)73540-0     Document Type: Article

References (30)

1. Monteagudo-Piqueras O, Sarria-Santamera A. Differences between men and women in hospital mortality and procedure utilization in acute myocardial infarction. Gac Sanit. 2006;20:77-88.
2. Bardají A, Bueno H, Fernández-Ortiz A, Cequier A, Eras M. Tratamiento y evolución a corto plazo de los pacientes ancianos con infarto agudo de miocardio ingresados en hospitales con disponibilidad de angioplastia primaria. El registro TRIANA.. Rev Esp Cardiol. 2005;58:351-8.
3. White HD, Barbash GI, Califa RM, Simes RJ, Granger CB, Weavef WD, et al. Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-I trial. Circulation. 1996;94:1826-33.
4. Marrugat J, Gil M, Masia R, Sala J, Elosua R, Anto JM. Role of age and sex in short-term and long term mortality after a first Q wave myocardial infarction. J Epidemiol Community Health. 2001;55:487-93.
5. Lansky AJ, Hochman JS, Ward PA, Mintz GS, Fabunmi R, Berger PB, et al. Percutaneous coronary interventions and adjunctive pharmacotherapy in women. A statement for healthcare professionals from the American Heart Association. Circulation. 2005;111:940-53.
6. Popitean L, Barthez O, Rioufol G, Zeller M, Arbués I, Dentan G, et al. RICO Survey Working Group. Gerontology. 2005;51:409-15.
7. Echanove I, Cavades A, Velasco JA, Pomar F, Valls F, Francés M. Características diferenciales y supervivencia del infarto agudo de miocardio en la mujer. Registro de infartos agudos de miocardio de la ciudad de Valencia. Rev Esp Cardiol. 1997;50:851-9.
8. Barakat K, Wilkinson P, Suliman JA. Acute myocardial infarction in women: Contribution of treatment variables to adverse outcome. Am Heart J. 2000;140:740-6.
9. Thiemannn DR, Coresh J, Schulman S, Gertenblith G, Oetgen WJ, Powe NR. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation. 2000;101:2239-46.
10. Gershlick AH, Stephens-Lloyd A, Hughes S, Abrams KR, Stevens SE, Uren NG, et al for the REACT Trial Investigators. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005;353:2758-68.
11. Davis KB, Chaitman B, Ryan T, Bittner V, Kennedy W. Comparison of 15 year survival for men and women after initial medical or surgical treatment for coronary artery disease. ACASS Registry Study. J Am Coll Cardiol. 1995;25:1000-9.
12. Ahumada M, Cabades A, Valencia J, Cebrian J, Payá E, Morillas P, et al. El reinfarto como complicación del infarto agudo de miocardio. Datos del registro PRIMVAC. Rev Esp Cardiol. 2005;58:13-9.
13. Tunstalll-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries, in four continents. Circulation. 1994;90:583-612.
14. Ruiz-Cantero MT, Verdú-Delgado M. Sesgo de género en el esfuerzo terapéutico. Gac Sanit. 2004;18 Suppl 1:118-25.
15. Annand SS, Chun C, Mehta S. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol. 2005;46:1845-51.
16. Gottlieb S, Harpaz D, Shotan A. Sex differences in management and outcome after acute myocardial in the 1990. Circulation. 2000;103:2484-98.
17. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med. 1996;334:1311-5.
18. Barron H, Bowlby L, Breen T, Rogers WJ, Canto JG, Zhang Y, et al. Use of reperfusion therapy for acute myocardial infarction in the United States. Circulation. 1998;97:1150-6.
19. Krumholz H, Murillo JE, Chen J, Vaccarino V, Radford MJ, Ellerbeck EF, et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA. 1997;277:1683-8.
20. Curtis JP, Portnay EL Wang Y, McNamara RL, Herrin J, Bradley EH, et al. The prehospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000-2002: findings from the National Registry of Myocardial Infarction-4. J Am Coll Cardiol. 2006;47:1544-52.
21. Demirovic J, Blackburn H, McGovern PG, Luepker R, Sprafka JM, Gilberston D. Sex differences in early mortality after acute myocardial infarction. Am J Cardiol. 1995;75:1096-101.
22. Toffler GH, Stone PH, Muller JE, Willich SN, Davis V, Poole WK, et al and the MILLIS Group. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol. 1987;9:473-82.
23. Fibrinolytic therapy Trials (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results of all randomized trials of more than 1000 patients. Lancet. 1994;343:311-22.
24. Dangelser G, Gottwalles Y, Huk M, De Poli F, Levai L, Boulenc JM, et al. Acute ST-elevation myocardial infarction in the elderly (> 75 years). Results from a regional multicenter study. Presse Med. 2005;34:983-9.
25. Bosch X, López A. Efecto del tratamiento trombolítico sobre el pronóstico del infarto de miocardio en el sexo femenino. Rev Esp Cardiol. 1994;47:32-9.
26. Pabón P, Arós F, San José JM, Bermejo J, López-Bescós L, Montón A. Trombólisis en el anciano con infarto agudo de miocardio. El estudio PRIAMHO. Rev Esp Cardiol. 2000;53:1443-52.
27. Tamis-Holland JE, Palazzo A, Stebbins AL, Slater JN, Boland J, Ellis SG, et al for the GUSTO II-B Angioplasty Substudy Investigators. Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy. Am Heart J. 2004;147:133-9.
28. Berger A, Radford M, Wang Y, Krumholz H. Thrombolytic therapy in older patients. J Am Coll Cardiol. 2000;36:366-74.
29. Wallentin L, Goldstein P, Armstrong PW, Granger CW, Adgey AA, Arntz HR, et al. Efficacy and safety of tenecteplase in combination with the low molecular weigh heparin enoxaparin or unfractioned heparin in the prehospital setting. ASSENT-3 PLUS randomized trial in myocardial infarction. Circulation. 2003;108:135-42.
30. De Boer MJ, Ottervanger JP, Van'tHof AWJ, Hoorntje JACA, Suryapranata H, Zijlstra F. Reperfusion therapy in elderly patients with acute myocardial infarction. A randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 2002;39:1723-8.